李钦传教授曾先后参与完成十余项各级科研项目，有着长期从事肺癌等胸部肿瘤的临床诊治和相关科研工作，近期主持承担项目主要集中在非小细胞肺癌（NSCLC）、肿瘤免疫、非编码RNA调控、肺癌干细胞等研究领域。主持国自然2项，省部级课题8项，获省部级科研成果5项，实用新型专利3项，同时还是浦东新区卫健委重点学科群（肿瘤医学）负责人，具有丰富的临床科研经验和管理能力。 近五年重要论文： (1) Li Y, Yu S, Li L, Chen J, Quan M, Li Q, Gao Y. KLF4-mediated upregulation of CD9 and CD81 suppresses hepatocellular carcinoma development via JNK signaling. Cell Death Dis. 2020 Apr 29;11(4):299. (2) Wang M, Zhou J, Zhang L, Zhao Y, Zhang N, Wang L, Zhu W, He X, Zhu H, Xu W, Pan Q, Mao A, Li Q, Wang L. Surgical treatment of ovarian cancer liver metastasis. Hepatobiliary Surg Nutr. 2019 Apr;8(2):129-137. (3) Chen, Guoting#; Han, Ning#; Li, Guofeng; Li, Xin; Li, Guang; Li, Zengchun; Li, Qinchuan*; Time course analysis based on gene expression profile and identification of target molecules for colorectal cancer, Cancer Cell International, 2016, 16. (5) Wang Guangxue#; Gormley Michael#; Qiao Jing#; Zhao Qian; Wang Min; Di Sante Gabriele; Deng Shengqiong; Dong Lin; Pestell Tim; Ju Xiaoming; Casimiro Mathew C; Addya Sankar; Fortina Paolo; Tozeren Ayden; Li Qinchuan; Yu Zuoren*; Pestell Richard G*; Cyclin D1-mediated microRNA expression signature predicts breast cancer outcome, Theranostics, 2018, 8(8): 2251-2263.